Are you interested in business opportunities in the field of cell and gene therapy in the Netherlands? The Netherlands Foreign Investment Agency (NFIA) will be at The Cell & Gene Meeting on the Mesa to showcase the Dutch life sciences & health ecosystem and prospects for international innovation and collaboration.

The Netherlands is playing a key role in advancing cell & gene therapies. The country’s high concentration of world-leading research talent, its business-oriented R&D facilities, startups and multinationals, and a supportive government, all make the country an ideal base to develop cell and gene therapy towards commercial viability, helping to treat patients around the globe.

Advancing cell & gene therapies in the Netherlands

Find out what the Netherlands can offer your company at Cell & Gene on the Mesa. The event is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.

Would you like to meet with our team at the event?

Contact our Sector Specialist for Life Sciences & Health, Sandra de Wild-Chardonnens.
Or connect with our LSH team anytime via [email protected].